Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Family Medicine
 Disease Category: Cancer Prevention
Location: United States, CA

Trial Information

Quadrivalent Human Papillomavirus (qHPV) Vaccine in Cancer Survivors: Cross Sectional Survey and Phase II Open-Label Vaccine Trial A Consortium for Pediatric Interventional Research Study

You have been asked to participate in this research study because you are a cancer survivor between 9 and 26 years of age, you completed your cancer therapy 1 to 5 years ago, and you recently participated in the HPV vaccination survey study.  Your responses to the Human Papillomavirus (HPV) vaccination survey indicate that you have not received any doses of the HPV vaccine.  The purpose of this study is to determine how well cancer survivors are able to make and maintain protective antibodies against HPV infection after receiving three doses of the HPV vaccine. Your participation in this study is expected to last 2 years.    

Patient Inclusion/Exclusion Criteria:


- See http://clinicaltrials.coh.org for additional information.


City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Map

Research Center Information: City of Hope

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.